Talking Medication Safety in Specialty Pharmacy with ISMP | NASP Specialty Pharmacy Podcast
- 28m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode explores medication safety in specialty pharmacy through a discussion between host Sheila Arkat and guest Dr. Rita Jew, President of the Institute for Safe Medication Practices (ISMP). Dr. Jew details how specialty pharmacy presents high-risk challenges due to complex drug therapies, narrow therapeutic indices, self-injection requirements at home, and intricate delivery workflows. The conversation examines common shipping errors, the dangers of benchmarking low medication error rates, and the tools ISMP offers, including proactive risk assessments and safety self-assessments. Listeners learn actionable strategies for building resilient systems and cultivating a strong safety culture.
- Avoid using low medication error rates as a performance metric because it discourages reporting and hides systemic risks. 12:20
- Confirm patient addresses early in the onboarding process and separate outdated delivery details to prevent shipping errors. 16:54
- Use multi-role self-assessments involving administrators, pharmacists, and technicians to uncover gaps between official policy and actual pharmacy practice. 24:33
Highlights
- 3:10
ISMP Mission and Focusinsight
Dr. Rita Jew explains that ISMP is an independent nonprofit organization devoted entirely to medication safety, analyzing error reports and creating practical strategies to prevent patient harm.
- 6:35
Specialty Medication Risksinsight
Specialty drugs involve high complexity, narrow therapeutic indexes, and complex dosing, which require specialized handling, onboarding, and ongoing patient monitoring.
- 12:20
Flaw in Error Ratesdebate
Dr. Jew warns against benchmarking low medication error rates, arguing that if organizations want zero errors, they just need to tell people to stop reporting.
- 14:30
Shipping and Delivery Errorsdata
A specialty pharmacy reported that shipping and delivery errors account for nearly half of their internally reported errors, ranging from wrong addresses to delayed therapies.
- 20:08
The Cold Chain Comparisonstory
Dr. Jew shares an anecdote about receiving commercial shipments of fish with embedded RFID tracking and temperature controls, arguing specialty drugs deserve similar logistical rigor.
- 22:39
Proactive Risk Assessmentsstrategy
ISMP provides a library of proactive risk assessments for over 350 drugs and biosimilars to help specialty pharmacies evaluate new FDA-approved medications efficiently.
About this episode
In this episode, Sheila Arquette, President & CEO of NASP, speaks with Rita Jew, PharmD, MBA, President of the Institute for Safe Medication Practices (ISMP), about what it takes to keep specialty medication use safe. They discuss the distinct risks of specialty medications and detail ISMP's mission to prevent medication errors, providing drug-specific risk assessments, resources, and interactive tools that help pharmacies uncover gaps between policy and practice.
Transcript
4,060 words · 4 speakers
Topics
- Medication Safety
- Specialty Pharmacy
- Pharmacy Operations
- Supply Chain Management
- Healthcare Quality
Page updated · transcript and summary are machine-generated